AT (@ryu_tay) 's Twitter Profile
AT

@ryu_tay

ASX investing whinging diary | High Growth compounder 🚀 | No financial background or expert 🤷🏻‍♂️ | Don’t judge as I know nothing 🤘

ID: 1306969060865794048

calendar_today18-09-2020 14:51:30

11,11K Tweet

961 Takipçi

656 Takip Edilen

AT (@ryu_tay) 's Twitter Profile Photo
AT
@ryu_tay

3 months ago

Citi raises $RMD ResMed's target price to $45 and lifts EPS forecasts by 0–4% for FY25–FY27. Sees strong EPS CAGR of 15%, US$1.5bn+ cash flow, and attractive 20x FY27 P/E. US tariffs won’t impact CPAP devices; focus remains on educating GLP-1 prescribers.